These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3260160)

  • 21. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein.
    McIntosh KR; Linsley PS; Bacha PA; Drachman DB
    J Neuroimmunol; 1998 Jul; 87(1-2):136-46. PubMed ID: 9670855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions.
    Brenner T; Zielinski A; Argov Z; Abramsky O
    Tumour Biol; 1984; 5(5):263-74. PubMed ID: 6085187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AChR-specific immunosuppressive therapy of myasthenia gravis.
    Luo J; Lindstrom J
    Biochem Pharmacol; 2015 Oct; 97(4):609-619. PubMed ID: 26215875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune regulation of experimental myasthenia.
    Fuchs S; Bartfeld D; Eshhar Z; Feingold C; Mochly-Rosen D; Novick D; Schwartz M; Tarrab-Hazdai R
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):634-43. PubMed ID: 7400824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
    J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Huang WX
    Scand J Immunol; 1993 May; 37(5):615-22. PubMed ID: 7683442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Spaans F; De Baets MH
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.
    Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L
    Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of thalidomide on experimental autoimmune myasthenia gravis.
    Crain E; McIntosh KR; Gordon G; Pestronk A; Drachman DB
    J Autoimmun; 1989 Apr; 2(2):197-202. PubMed ID: 2788425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
    J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
    Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.
    Poulas K; Tsouloufis T; Tzartos SJ
    Clin Exp Immunol; 2000 May; 120(2):363-8. PubMed ID: 10792389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA; Yeh TM; Edlund SA
    Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.